Scavilla Daniel T. - 08 Aug 2025 Form 4 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role
President, CEO & Member of BOD, Director
Signature
/s/ Jessica Causey, Attorney-in-Fact for Daniel T. Scavilla
Issuer symbol
XRAY
Transactions as of
08 Aug 2025
Net transactions value
$0
Form type
4
Filing time
12 Aug 2025, 17:25:20 UTC
Previous filing
15 Jul 2025
Next filing
15 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Scavilla Daniel T President, CEO & Member of BOD, Director C/O DENTSPLY SIRONA INC, 13320-B BALLANTYNE CORPORATE PLACE, CHARLOTTE /s/ Jessica Causey, Attorney-in-Fact for Daniel T. Scavilla 12 Aug 2025 0001642439

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding XRAY Common Stock 17,475 08 Aug 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XRAY Stock Option (Right to Buy) Award $0 +1,102,600 $0.000000 1,102,600 08 Aug 2025 Common Stock 1,102,600 $12.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options vest in annual one-third (1/3) increments over a three (3) year period ending August 8, 2028.